Discover the new educational ERN Rare-Liver webinar series launched in November 2020.
In this sixth webinar which took place on 13 July 2021, Professor Ansgar Lohse, Dr Eleonora De Martin and Dr Christina Weiler-Normann discussed about how to optimize standard therapy for autoimmune hepatitis, what are the criteria of acute severe autoimmune hepatitis as well as which 3rd line therapy to use for autoimmune hepatitis, respectively.
- General practitioners
- Health care professionals
1. Optimizing standard therapy for Autoimmune Hepatitis
2. Acute severe Autoimmune Hepatitis
3. 3rd line therapy for Autoimmune Hepatitis
|Prof. Dr Ansgar W. Lohse is Director of the I. Department of Medicine at the University Medical Centre Hamburg-Eppendorf (UKE), Germany, since 2005. He is also the coordinator of the European Reference Network on hepatological Diseases (ERN RARE-LIVER) since 2018. He studied medicine and philosophy in Göttingen, London and Boston from 1978 – 1984 and received his Doctorate in 1987 at the University of Marburg. After a two-year research stay at the Weizmann Institute of Science in Israel he worked both clinically and in research at the Johannes Gutenberg-University Mainz. He is specialist in gastroenterology and infectious diseases, with special interest in basic and clinical immunology.|
|Eleonora De Martin, MD, Phd, is a transplant hepatologist at Centre Hépato-Biliaire, Paul Brousse Hospital in France. She is the Vice-Chair of ILTS Vanguard Committee and topic coordinator of the ILTS Liver Transplant Immunology Special Interest Group. Her fields of interest include various aspect of liver transplantation, autoimmune hepatitis in particular severe acute and fulminant forms and hepatic toxicity of immunotherapy for metastatic cancer.|
|Dr Christina Weiler-Normann is working as a consultant at I. Department of Medicine and Martin Zeitz Centre for Rare Diseases at University Medical Centre Hamburg-Eppendorf, Germany. She studied Human Medicine from 1995 – 2002, finished her Dissertation in Human Medicine (Dr med.) under the supervision of Prof. Dr Lohse in 2002 and has worked as junior doctor from 2002 – 2003 at the University of Mainz, Germany. From 2004 – 2006 she worked as a Postdoctoral Fellow in the National Institutes of Health, Bethesda, USA. She is a Specialist in Gastroenterology and Hepatology with a special interest in autoimmune liver diseases.|